NYSE·Healthcare·USD
Henter pris…
Værdiansættelse (TTM)
P/E
8,2
10th %ile · 62pEV/EBITDA
—
P/B
2,5
32nd %ile · 64pP/S
1,5
34th %ile · 70pEV/Sales
2,1
38th %ile · 70pDiv yield
—
Regnskabsdata (SEC EDGAR)
Årsregnskab (senest 5 år)
| FY 2025 | FY 2024 | FY 2024 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Omsætning | 8.325,0 mio. | 8.254,0 mio. | — | — | 8.197,0 mio. |
| Bruttoresultat | 4.451,0 mio. | 4.593,0 mio. | — | — | 4.693,0 mio. |
| Nettoresultat | 1.556,0 mio. | 479,0 mio. | — | — | 1.346,0 mio. |
| Op. cash flow | 369,0 mio. | 1.185,0 mio. | — | — | 1.915,0 mio. |
| Capex | 379,0 mio. | 380,0 mio. | — | — | 290,0 mio. |
| Free cash flow | -10,0 mio. | 805,0 mio. | — | — | 1.625,0 mio. |
| EPS | 8,94 | 2,77 | — | — | 7,79 |
| Aktiver i alt | 14.294,0 mio. | 14.457,0 mio. | — | — | 13.943,0 mio. |
| Egenkapital | 5.049,0 mio. | 2.959,0 mio. | — | — | 11.666,0 mio. |
| Rentebærende gæld | 5.035,0 mio. | 16.420,0 mio. | — | — | 0,0 mio. |
| Aktier udestående | 173,5 mio. | 172,8 mio. | 172,7 mio. | 0,0 mio. | 0,0 mio. |
Kvartalsregnskab (senest 4 kvartaler)
| Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|
| Omsætning | 6.327,0 mio. | 4.231,0 mio. | 2.070,0 mio. | — |
| Bruttoresultat | 3.424,0 mio. | 2.289,0 mio. | 1.114,0 mio. | — |
| Nettoresultat | 1.493,0 mio. | 227,0 mio. | 137,0 mio. | — |
| Op. cash flow | 274,0 mio. | 198,0 mio. | 29,0 mio. | — |
| Capex | 316,0 mio. | 219,0 mio. | 109,0 mio. | — |
| Free cash flow | -42,0 mio. | -21,0 mio. | -80,0 mio. | — |
| EPS | 8,58 | 1,31 | 0,79 | — |
| Aktiver i alt | 13.973,0 mio. | 15.074,0 mio. | 14.527,0 mio. | 14.457,0 mio. |
| Egenkapital | 4.986,0 mio. | 3.645,0 mio. | 3.262,0 mio. | 2.959,0 mio. |
| Rentebærende gæld | 5.137,0 mio. | 7.815,0 mio. | 8.013,0 mio. | 24.630,0 mio. |
| Aktier udestående | 173,4 mio. | 173,4 mio. | 173,0 mio. | 172,8 mio. |